Pediatric Advanced Life Support (PALS) includes a series of algorithmic medical procedures and techniques designed for the urgent treatment of respiratory emergencies, cardiac arrest and other life threatening situations. The course expands upon basic life support with more advanced skills such as Electrocardiogram (ECG) rhythm interpretation for core PALS rhythms, airway management and appropriate adjuncts, PALS drugs and pharmacology, practical application of PALS rhythms and drugs, and effective high-performance team skills for Basic Life Support and PALS. Many hospitals and other medical facilities require this advanced training for anyone who may work with pediatric cardiac patients.
This course is nationally accredited in joint partnership with the Postgraduate Institution of Medicine. Upon course completion, you will receive 8 CEU/CME credits.
Because good Pediatric Basic Life Support (BLS) skills are foundational to PALS skills, a BLS certification is strongly encouraged, or in most cases, a pre-requisite for taking the PALS certification. In addition, participants who enter the ProPALS course are required to have already obtained the basic knowledge and skills in Advanced Life Support.
Total course time includes 3 hours and 10 minutes of video training as well as knowledge reviews, final test, remedial help and reviewing downloaded material.
Release date: January 1, 2024
Expiration date: December 31, 2024
Estimated time to complete activity: 2 to 8 hours depending on activity
Hardware needed: Desktop, laptop, tablet or phone
To contact the Postgraduate Institute for Medicine please visit www.pimed.com.
Jointly provided by Postgraduate Institute for Medicine and ProTrainings
ProTrainings is pleased to offer CME/CE/CEU credits to all students for their BLS, PALS, and ACLS certification and recertification courses. These credits are approved through a joint providership with the Postgraduate Institute for Medicine (PIM) for a variety of professions.
This activity has been designed to meet the educational needs of healthcare providers involved in the care of patients in cardiac arrest.
After completing this activity, the participant should be better able to:
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and ProTrainings. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and ProTrainings. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Postgraduate Institute for Medicine designates this continuing education activity for 8.0 contact hours (0.8 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - JA4008162-9999-24-037-H99-P and JA4008162-9999-24-037-H99-T)
When recertifying, Postgraduate Institute for Medicine designates this continuing education activity for 4.0 contact hours (0.4 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - JA4008162-9999-24-034-H99-P)
Type of Activity: Knowledge
Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
The maximum number of hours awarded for this Continuing Nursing Education activity is 8.0 contact hours. When recertifying, the educational activity is 4.0 contact hours, provided by Postgraduate Institute for Medicine.
This continuing nursing education activity was approved by the California Board of Registered Nursing (CBRN). PIM’s provider number is CEP13485.
This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint sponsorship efforts between Postgraduate Institute for Medicine and ProTrainings.
Postgraduate Institute for Medicine is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of the credit hours by boards of dentistry.
Postgraduate Institute for Medicine designates this activity for 8.0 continuing education credits.
When recertifying, this educational activity for 4.0 contact hours is provided by Postgraduate Institute for Medicine.
Concerns or complaints about a CE Provider may be directed to the provider or to ADA CERP at http://www.ada.org/cerp.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The PIM planners and managers have nothing to disclose.
The ProTrainings faculty — Roy Shaw — hereby states that he or his spouse/life partner have no financial relationships, relationships to products or devices, or other commercial interests related to the content of this CME activity of any amount during the past 12 months.
The medical reviewers — Jason Courtade and Dr. Eric Egeler — hereby state that they or their spouse/life partner have no financial relationships, relationships to products or devices, or other commercial interests related to the content of this CME activity of any amount during the past 12 months.
There are no fees for participating and receiving CME credit for this activity. During the period January 1, 2024 through December 31, 2024, participants must read the learning objectives and faculty disclosures and study the educational activity.
If you wish to receive acknowledgment for completing this activity, please complete the evaluation on www.cmeuniversity.com. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 18357. Upon registering and completing the activity evaluation, your certificate will be made available immediately.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
“Thorough and concise information”
“Highly recommended. ”